It was shown previously that the REL1 mitochondrial RNA ligase in Trypanosoma brucei was a vital gene and disruption affected RNA editing in vivo, whereas the REL2 RNA ligase gene could be down-regulated with no effect on cell growth or on RNA editing. We performed down-regulation of REL1 in procyclic T. brucei (midgut insect forms) by RNA interference and found a 40 -50% inhibition of Cyb editing, which has only U-insertions, as well as a similar inhibition of ND7 editing, which has both U-insertions and U-deletions. In addition, both Uinsertion and U-deletion in vitro pre-cleaved editing were inhibited to similar extents. We also found little if any effect of REL1 down-regulation on the sedimentation coefficient or abundance of the RNA ligase-containing L-complex (Aphasizhev, R., Aphasizheva, I., Nelson, R. E., Gao, G., Simpson, A. M., Kang, X., Falick, A. M., Sbicego, S., and Simpson, L. (2003) EMBO J. 22, 913-924), suggesting that the inhibition of both insertion and deletion editing was not due to a disruption of the L-complex. Together with the evidence that down-regulation of REL2 has no effect on cell growth or on RNA editing in vivo or in vitro, these data suggest that the REL1 RNA ligase may be active in vivo in both U-insertion and U-deletion editing. The in vivo biological role of REL2 remains obscure.
Uridine (U) 1 -insertion/deletion RNA editing occurs in the mitochondrion of kinetoplastid protozoa (1, 2) . The mechanism in all cases but one involves the annealing of a trans-acting guide RNA to the pre-edited mRNA just downstream of the initial editing site, specific cleavage of the mRNA at the unpaired editing site, deletion of unpaired uridines or addition of uridines to the 3Ј end of the 5Ј cleavage fragment, which can form base pairs with guiding A or G nucleotides in the guide RNA, and ligation of the 5Ј and 3Ј cleavage fragments (3) (4) (5) (6) (7) (8) . Two mitochondrial RNA ligases have been identified in Trypanosoma brucei (9 -11) . Conditional disruption of both alleles of the REL1 ligase in bloodstream T. brucei was lethal and affected in vivo RNA editing (12) . Conditional expression of a mitochondrial targeted REL1 transgene with a K86R mutation at the AMP-binding site in procyclic T. brucei also produced a growth phenotype and disrupted RNA editing (13) . Significant effects on ND7 and MURF2 editing were reported, both of which involve both U-insertions and U-deletions, but no detectable effects on Cyb and COII editing were reported, both of which involve only U-insertions (13) . Full round in vitro Udeletion editing using mitochondrial extract from cells expressing the dominant negative REL1 transgene was inhibited ϳ50%, whereas U-insertion editing was apparently unaffected (13) . It was also reported that more ATP was required for in vitro U-deletion editing than for U-insertion editing, and that this correlated with the levels of ATP required for adenylation of REL1 and REL2, respectively. In addition, we showed that overexpression of tandem affinity purification-tagged REL1 in Leishmania tarentolae causes the appearance of a minor Lsubcomplex containing REL1, LC-3, LC6a, and LC-4, which is the homologue of MP63 in T. brucei (14) , 2 and others have found another L-subcomplex consisting of REL2, RET2, and MP81. 3 These observations led to the model that REL1 mediates ligation at U-deletion editing sites and REL2 mediates ligation at U-insertion sites (13, 15) . The fact that down-regulation of expression of the REL2 RNA ligase by conditional RNAi in procyclic or bloodstream T. brucei showed no phenotype, either in terms of cell growth or editing (16) , was interpreted as a substitution of the REL2 role by REL1, although the reverse does not occur.
In this paper, we have re-analyzed the effects of RNAi downregulation of REL1 and REL2 in terms of this hypothesis and we conclude that the situation may be more complex than originally envisioned.
EXPERIMENTAL PROCEDURES
Trypanosome Culture and RNAi-To construct the pREL1-H2H vector for inducible RNAi, two 495-bp PCR fragments from the 5Ј end of the T. brucei REL1 coding region were inserted in a head-to-head configuration adjacent to a green fluorescent protein stuffer fragment under the control of a tetracycline-regulatable procyclic acidic repetitive protein promoter (17) . The vector was transfected into procyclic T. brucei strain 29 -13 cells (18) , and drug-resistant cell clones were selected by plating on agarose (19) . Cells were cultured in SDM-79 medium, and RNAi was induced with 1 g/ml tetracycline. Cells were maintained in log phase growth by daily dilution. The pREL2-H2H vector was constructed similarly with a 456-nucleotide fragment (nucleotides 69 -524) of REL2 in a head to head configuration.
Oligonucleotides used for PCR of REL1 and REL2 (added restriction sites are in boldface) are as follows: for REL1, 5076, 5Ј-AAG CTT ATG CAA CTC CAA AGG TTG GG-3Ј (1 st forward primer with HindIII site); 5077, 5Ј-TCT AGA ATA CTT GGC ACC AAA CAG TT-3Ј (1 st reverse * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. RNA Analysis-Total RNA was purified by the acid guanidium isothiocyanate method (20) . Primer extension was performed as described previously (21) . Cyb (oligonucleotide 3812) and Murf2 (oligonucleotide 3807) mRNAs were analyzed by run-off extensions. COI (oligonucleotide 3808), COII (oligonucleotide 3809), ND7 (oligonucleotide 4282), A6 (oligonucleotide 3882), and calmodulin (oligonucleotide 3813) mRNAs were analyzed by poisoned primer extension using ddGTP to chainterminate the extensions at the first C residue after 26 editing sites for A6, the entire editing domain for COII, and 9 editing sites for ND7 (22) . For normalization, oligonucleotides 3813 and 3808 for the cytosolic calmodulin mRNA and the never-edited COI mRNA were extended in the same reaction. The following oligonucleotides were used: 3807, 5Ј-CAACCTGACATTAAAAGAC-3Ј; 3808, 5Ј-GTAATGAGTACGTTGTAA-AACTG-3Ј; 3809, 5Ј-ATTTCATTACACCTACCAGG-3Ј; 3812, 5Ј-GTTC-TAATACATAACAAATCAAAAACACG-3Ј; 3813, 5Ј-GTTGATCGGCCA-TCGTAAATCAAGTGGATG-3Ј; 3882, 5Ј-ATAAACTAGAATAAGATAT-TGAGG-3Ј; and 4282, 5Ј-CTTTTCTGTACCACGATGC-3Ј.
Northern Analysis-Total RNA (30 g) was fractionated on a 1.5% agarose-formaldehyde gel in 20 mM MOPS, 5 mM sodium acetate, and 1 mM EDTA, pH 7.0, and the gel was blotted onto a Zeta-probe membrane (Bio-Rad). The filter was hybridized with full-length REL1 or REL2 PCR-amplified DNA labeled with [␣-
32 P]ATP using the Prime-It II random primer labeling kit (Stratagene).
Extract Preparation, Glycerol Gradient Sedimentation, and Native Gel Electrophoresis-Purified mitochondria (25 mg protein/ml) were lysed with 0.5% Nonidet P-40 in 10 mM Tris-HCl, pH 8.0, 10 mM MgCl 2 , and 60 mM KCl. The clarified extract (300 l) was centrifuged on a 10 -30% glycerol gradient in the SW41 rotor (Beckman) for 20 h at 30,000 rpm, and 150.75-ml fractions were collected from the top using the Isco density gradient fractionator. Aliquots (10 l) of each fraction were mixed with 0.5 l (10 Ci/l) of [␣-32 P]ATP for 30 min at 27°C. The reaction was mixed with SDS loading buffer for denaturing gradient gel analysis, and the gels were blotted onto nitrocellulose membranes (Protran) for Western analysis. For both adenylation (23) and Western blot analysis, an aliquot from fraction 9 of an identical gradient of mitochondrial extract from untransfected 29 -13 cells was used as an internal loading control in each gel. Sedimentation values were calculated using aldolase (9 S), thyroglobulin (19 S) and E. coli ribosome 30 S subunits.
RNA Substrates and in Vitro Editing-The following RNA substrates were chemically synthesized (Oligos Etc. and Xeragon) and gel-purified: 5Ј fragment, 5Ј-GCACUACACGAUAAAUAUAAAAAG-3Ј; 5Ј-UU fragment, 5Ј-GCACUACACGAUAAAUAUAAAAAGUU-3Ј; 3Ј fragment, 5Ј-AACAUUAUGCUUCUUCGddC-3Ј; AG brRNA, 5Ј-AAGAAGCAUAAUGUUAGCUUUUUAUAUUUAUCGUGUAGUCddG-3Ј; and 0 brRNA, 5Ј-AAGAAGCAUAAUGUUCUUUUUAUAUUUAUCGUGUAGUCdd-G-3Ј.
RNAs were 5Ј-phosphorylated with T4 polynucleotide kinase (Invitrogen) and [␥-32 P]ATP. Complementary RNAs were annealed by heating and slow-cooling. For in vitro editing assays, the L-complex fractions (8 -10) were pooled and concentrated to 300 l. The concentrated gradient fractions were stored at Ϫ20°C in 50% glycerol, 1 mg/ml bovine serum albumin, and 1 mM dithiothreitol. The fractions were fractionated by electrophoresis on 8 -16% denaturing gradient gels, and the gels were stained with Coomassie Blue (Sigma) to monitor the protein concentrations. The in vitro editing reactions were performed at 27°C for 2 h in 20 l of 50 mM Tris-HCl, pH 7.5, 10 mM MgCl 2 , 1 mM dithiothreitol, and 1 mM ATP. 2 mM UTP was added for the insertion reaction. The products were separated in a sequencing gel and detected by autoradiography.
RESULTS

Down-regulation of REL1 Ligase Expression Inhibits Both U-insertion and U-deletion Editing in
Vivo-Down-regulation of REL1 by conditional RNAi produced a growth inhibition by day 6 of induction ( Fig. 1A) , which was preceded by a selective degradation of REL1 mRNA and down-regulation of REL1 protein expression by day 3 (Fig. 1B) . A correlated downregulation of the MP63 L-complex protein was also observed (Fig. 1C) . The relative abundances of edited and pre-edited FIG. 1 . A, effect of tetracycline induction of RNAi of REL1 and REL2 expression on growth of procyclic T. brucei. The cells were maintained in log phase by daily dilutions. The cumulative number of cell divisions is plotted versus the time after the addition of tetracycline (tet). Open triangles, REL1 RNAi ϩ tet; filled triangles, REL1 RNAi no tet; open circles, REL2 RNAi ϩ tet; filled circles, REL2 RNAi no tet. B, specific degradation of REL1 mRNA by induction of REL1 RNAi and specific degradation of REL2 mRNA by induction of REL2 RNAi. Total cell RNA was isolated from cells 0, 3, and 7 days after addition of tetracycline and fractionated by electrophoresis. The gels were blotted, and the blots were hybridized with a labeled REL1 probe (left panel) or a labeled REL2 probe (right panel). Hybridization of ␤-tubulin mRNA was used as a loading control. C, specific down-regulation of REL1 protein expression by REL1 RNAi and REL2 protein expression by REL2 RNAi. Mitochondrial extract from 29 -13 cells and from the transfected cells 0, 3, or 5 days after the addition of tetracycline was fractionated by SDS acrylamide gel electrophoresis. Western analysis was performed using antibodies against the MP81, MP63, REL1, and REL2 proteins. Left, REL1 RNAi. Right, REL2 RNAi. mRNAs were examined for five genes by primer extension analysis (Fig. 2) . Editing of Cyb and ND7 mRNAs decreased 40 -70% after 7 days of RNAi induction, and editing of COII, MURF2, and A6 mRNAs decreased slightly. There was no change in the abundance of pre-edited RNAs or the neveredited COI mRNA, suggesting a specific effect on editing.
As reported previously (16) , down-regulation of REL2 by RNAi produced no growth phenotype (Fig. 1A) or editing phenotype (Fig. 2) , although there was a selective decrease of REL2 mRNA by day 3 (Fig. 1B) and REL2 protein by day 3 (Fig. 1C) .
Down Regulation of REL1 Affects Both U-insertion and Udeletion Pre-cleaved in Vitro
Editing-Mitochondrial extracts from cells induced for REL1 RNAi for 0, 3, or 5 days were tested for pre-cleaved in vitro editing activity (Fig. 3) . U-insertion editing and U-deletion editing were inhibited to similar extents. There was no effect on the addition or deletion of 3Ј-terminal uridines to or from the 5Ј-mRNA cleavage fragment. In the case of REL2 RNAi, there were no detectable changes in the extent of U-insertion or U-deletion pre-cleaved in vitro editing (Fig. 3) .
Down Regulation of REL1 Has No Effect on the S Value or
Abundance of the L-Complex-One possible explanation for the inhibition of both U-insertion and U-deletion in vitro editing by down-regulation of REL1 would be that there was a decrease in stability of the L-complex. In fact, it was previously reported that knocking out of one REL1 allele in T. brucei procyclics produced a partial breakdown of the L-complex (13) . To test this possibility, mitochondrial extract from cells induced for REL1 RNAi for 0, 3, or 5 days was fractionated in a glycerol gradient and each fraction was incubated with [␣-32 P]ATP to label the REL1 and REL2 RNA ligases, which represent markers for the L-complex. It should be noted that the REL1 ligase was labeled to a greater extent than the REL2 ligase because of the latter being pre-charged with AMP (11). The S value of the L-complex did not change as the REL1 protein decreased in abundance (Fig. 4A) . Western analysis of each fraction using antibodies against MP81, MP63, and REL1 was also performed (Fig. 4A) . Despite the loss of detectable REL1 protein, the L-complex was unaffected in terms of location in the gradient and relative abundance. Down-regulation of REL2 likewise had no effect on the S value or relative abundance of the L-complex (Fig. 4B) . DISCUSSION The presence of two mitochondrial RNA ligases, both of which are components of the L-complex, has raised an interesting question. Several lines of evidence have led to the model that REL1 is involved in U-deletion editing and REL2 is involved in U-insertion editing (13, 15, 24) . The complete absence of any phenotype with REL2 down-regulation has been explained by the suggestion that REL1 can substitute for REL2 in the REL2 down-regulated cells and mediate both types of editing (13, 15) . The lethality of the REL1 knock-out has been explained by assuming that REL2 is not capable of substituting for REL1 in U-deletion editing.
The results presented in this paper raise some doubts about this model. We showed that down-regulation of REL1 expression affected the in vivo editing of different mRNAs to different extents, but the inhibitory effect was apparently correlated with the percentage of editing of the specific mRNA rather than with the presence of U-insertions alone or U-insertions and U-deletions. For example, the editing of Cyb mRNA, which only involves U-insertions, was inhibited to a similar extent as the editing of ND7 mRNA, which involves both U-insertions and U-deletions. The editing of A6, MURF2, and COII mRNAs, the former two involving both insertions and deletions and the latter involving only insertions, was inhibited to a lesser extent, both decreasing ϳ20% by day 7. The magnitude of the effect on editing appeared to be inversely correlated with the normal extent of editing, in that A6, MURF2, and COII editing is normally very efficient (Ͼ90% edited RNA), whereas Cyb and ND7 editing is less efficient (ϳ70% edited RNA). The reason for this variation in the extent of inhibition of editing with different mRNAs is not known. Furthermore, we showed that precleaved U-insertion and U-deletion in vitro editing were inhibited to similar extents. These results differ from those reported previously both in terms of the effect on Cyb mRNA editing in vivo and full-round in vitro editing (13), the reasons for which are not clear but may be related to the different modes of gene knockdown and to the different in vitro assays. We eliminated the possibility that RNAi down-regulation of REL1 affected the overall stability of the L-complex and thereby also affected U-insertion editing by showing that there was no large change in S value or abundance of the L-complex in the REL1 RNAiinduced cells. We conclude that the simplest interpretation is that REL1 performs ligations for both U-insertion and U-deletion editing and that REL2 is less active or even inactive in vivo, at least under these physiological conditions. We realize that the simplest interpretation is not always valid and that, for example, down-regulation of REL1 may affect the functional interaction of REL2 with other L-complex proteins and thereby also affect U-insertion editing, but this would have to be established. It is clear from both the apparently functional suborganization of proteins in the L-complex (14) and from the striking ATP titration correlations (15) that REL1 and REL2 probably have differing biological roles, but the precise nature of these roles is yet unclear. We speculate that REL2 may be active under different physiological or developmental conditions. The precise roles of these two RNA ligases await reconstitution of activities with recombinant proteins.
